HMD BioMedical Inc. Leads the Taiwan Medical Device Industry as the First MDSAP Certified Company. PDF Print E-mail
Written by BS   

Dr.Tim Hsu, G.M. of HMD BioMedical Inc.(left). is awarded by Mr. Bill Lin (right), G.M. of TÜV SÜD Taiwan


HMD BioMedical Inc. is committed to the development of medical device products, such as blood glucose monitoring system, since 2000.

Its medical equipment quality management system was rigorously reviewed and approved by TÜV SÜD, and was awarded the first MDSAP medical equipment single audit program certificate in Taiwan.

Leading the industry to meet the requirements of international quality management standards, HMD BioMedical enhances the competitiveness of Taiwan's medical device industry in the international market.

By organizing the management of the MDSAP system, HMD BioMedical ensure the stability of the quality of supply chain production and strengthen the risk assessment and safety management level.

Passing TÜV SÜD audit, HMD BioMedical won the MDSAP certificate, achieving the international level of quality management standards to provide customers with high quality, revealing its determination of medical device products.


The Medical Device Single Audit Program (MDSAP) is a proposal presented by the International Medical Device Regulators Forum (IMDRF). It is expected that a single audit can be used to achieve regulatory requirements in multiple countries. The integration of resources verified by laws and regulations will increase the efficiency and flexibility of management, speed up the introduction of medical products to the international market, and reduce the time and cost that medical equipment manufacturers are struggling with to meet the requirements of national laws and regulations.

The regulatory authorities currently involved in MDSAP include:

1. Australian Medical Supplies Agency (TGA)

2. Brazilian National Health Surveillance Agency (ANVISA)

3. Health Canada

4. U.S. Food and Drug Administration (FDA)

5. Ministry of Health, Labour and Welfare, Japan/MHLW/PMDA

TÜV SÜD, originating from Germany, which has always been rigorous in quality, has a professional team in the field of medical equipment, and it is also one of the few units that have MDSAP auditor qualifications. TÜV SÜD can provide customers with a complete MDSAP verification process, covering ISO 13485 medical equipment quality management system and all the specific requests made by the competent authorities participating in MDSAP.

About HMD BioMedical Inc.

Established in 2000 by Dr. Tim Hsu, HMD BioMedical is committed to the development of medical biotechnology and solutions in the field of human health and health care. Devoted in the manufacturing research and development of blood glucose monitoring system, HMD BioMedical is dedicated to provide safe and reliable products to help diabetes families lead a better life and improve the service quality of medical care professionals.


HMD’s Booth at "28st Indonesian Hospital Expo 2015" PDF Print E-mail


HMD BioMedical Inc., will display our Blood Glucose Monitoring System, and Blood Glucose Test Strips. Please come and view our booth. We look forward to seeing you there.


HMD BioMedical Booth Information


Event Name

Indonesian Hospital Expo 2015

Event Website


Wed, October 21 – Sat, October 24, 2015 9:00am – 5:00pm


Jakarta Convention Center


Jl. Jend. Gatot Subroto, South Jakarta 10270

P.O. Box 4916, Jakarta 10049, Indonesia




Blood Glucose Monitoring System

·        GlucoLeader Enhance

·        GlucoLeader POCT NS-101

·        GoodLife COPPER TOE SOCKS

HMD Biomedical launches Brazil BOT project PDF Print E-mail


.The BOT press release of HMD Biomedical and the Brazilian state-owned IQUEGO

HMD Biomedical, together with Brazil state-owned pharmaceutical enterprise Iquego, held a press conference on the 4th of June to publicly annouce its Brazil Blood Glucose BOT Project. The project will allow HMD Biomedical to provide blood glucose monitoring technology and products to the Brazilian public healthcare system for more than one billion blood glucose test strip each year under the IQUEGO-HMD co-brand business model.


Related news

Iquego fecha parceria com indústria chinesa

Iquego será 1ª empresa no Brasil a fabricar glicosímetros

Pioneirismo da Indústria Química do Estado de Goiás

巴西血糖檢測BOT 厚美德拿到手! (工商時報)

厚美德共品牌行銷 前進巴西 (經濟日報)

厚美德生技獲巴西BOT Q3出貨 (工商時報)

Dr Catherine Solano, medecin sexologue et auteur de La mecanique sexuelle des hommes », aux editions Robert Laffont. megalis 24 kw prix, moins cher cialis vente, comparatif kamagra en ligne - prix de zithromax Colmar
IQUEGO and HMD Taiwan both signed contract of partnership to produce glucose measurement devises in Goias state, Brazil PDF Print E-mail
Written by Sales Team   


Iquego Terá Tecnologia Chinesa Para Ser a Primeira Fabricante de Glicosímetros no Brasil

IQUEGO和HMD TaiwanInc.公司雙方簽署了在GOIAS州內生產糖尿病測量設備的合作案


財經編輯Brunno Falcao

Governor Marconi Perillo participated yesterday the board meeting of Industry State of Goiás Chemistry (IQUEGO) with Chinese representatives HMD Taiwan Inc. to formalize Technology Transfer Partnership for the production of glucose meters – devises required for the monitoring of blood glucose diabetic patients. Thus, the Goiás laboratory, mixed capital, becomes the pioneer in the manufacture of the item in Brazil. "Certainly, the signing of this agreement will be a milestone in the history of Iquego. Demonstrates a concrete action the new strategic model advocated by the current administration, "says Andrea Vecci, president of Iquego.

州長Marconi Perillo昨日參加了GOIAS州化學工業(IQUEGO)的高層會議,與同HMD Taiwan的代表團員,正式決議生產血糖儀的技術移轉的合作計劃,這是監控糖尿病患的葡萄糖濃度的必要設備。藉此合作,IQUEGO這家官股占大數的企業,將成為在巴西國內生產這種產品的先鋒。IQUEGO的CEO,Andrea Vecci女士表示,”我們可以確定,簽署這種合同將是IQUEGO的歷史上一個指標。它展現出由現任的經營團隊捍衛的一個新策略模式的確定動作”。


According to the governor Marconi Perillo, "to sign contract with HMD Biomedical, the IQUEGO is effective the first of a series of Product Development Partnerships (PDPs). The Product Development Partnership signed between IQUEGO and the HMD Biomedical, has the seal of the government of Goiás and intervention of the Ministry of Health. "With the support of the New Business team and other departments, the goal of the current management of Iquego is to promote an organizational restructuring, financial and marketing at the company.

據Marconi Perillo州長表示,”與HMD BioMedical簽合約後,IQUEGO將開啟一系列的產品開發合作計劃(PDPs),IQUEGO和HMD BioMedical之間簽署的合約,其中有GOIAS州政府代表的簽名及衛生部的見證”。加上新商機團隊和其他單位的協助下,IQUEGO現任的經營團隊其目標就是推廣公司在組織上,財務上以及市場營銷上的重整計劃。


With the agreements signed, the Goiás laboratory becomes pioneer in glucometers manufacturing in Brazil. The technology transfer model between public and private laboratories was established by the prosecution and, in the case of partnership with the Chinese company, ensure Iquego marketing for two years of product produced by the HMD. From the third year of the contract, the Goiás laboratory will also produce the glucometer. It is expected to be generated revenues of approximately BRL 200 million per year for the next three years.




Consulter un psychologue permettra se surmonter ces apprehensions et retrouver une sexualite epanouie. trouver generique cialis france, acheter propecia pas cher livraison rapide, ou puis je acheter du viagra - levitra livraison rapide Merignac
IQUEGO and HMD BioMedical Inc. will start the partnership for 5 years to produce meters and test strips for Brazilian Public Market of Health. PDF Print E-mail
Written by Sales Team   

A parceria entre a Iquego e a HMD Taiwan Inc. será de cinco anos e produzirá glicosímetros e também as tiras para a aferição de glicemia.


The IQUEGO will be the first company in Brazil to manufacture glucometers. The contract of Public Private Partnership(PPP) witch enable production of the equipment has just been signed by Goias Government, through the Department of Health and Chemical Industry of Goiás S/A (Iquego), with the HMD Biomedical Taiwan.


Objective of the contract is transfer the technology to the IQUEGO for a production of glucometer; this is portable equipment used for measuring glucose in blood, and assists in daily diabetes monitoring.


Highlighting the importance of public laboratories for the country, during the signing ceremony held this afternoon at the Palace Pedro Ludovico, CEO of the IQUEGO, Mrs. Andrea Vecci,also said that this is the first PPP Iquego and through it, the IQUEGO will be the first company in Brazil to manufacture such equipment in the country.

這個下午,在Pedro Ludovico府裡進行的簽署儀式之時,IQUEGOCEO Andrea Vecci女士強調公家實驗室為國家帶來的重要性,並說明這是IQUEGO的首次開辦的PPP,並且經由此PPPIQUEGO將是巴西第一家在國內生產這種設備的公司。

The partnership between the IQUEGO and the HMD Taiwan Inc. shall be five years and produce glucose meters and also the strips for measuring blood glucose. During this period the company will receive in Goiáschinese technicians that will promote the internationalization of technology, including investments in Iquego.


From 2017 the glucometer will be produced in the Iquego, and according to Mrs. Andrea Vecci, will no cost to the State. "And furthermore we have the advantage of being able to market this product with other public entities without going through bidding processes," she says.

2017年起,血糖儀將會在IQUEGO園區內生產,據Andrea Vecci女士表示,不會為州政府帶來任何的成本。除此之外,我們還會有銷售這些產品到其他的公家機構的優勢,無須經由投標程序

Mrs.Andrea Vecci also said that one of the current administration's goals is to innovate the portfolio of IQUEGO through Partnerships for Productive Development (PDP), with private companies that propose to transfer technology of its products, always in line with the policy Pharmaceutical Services of the Ministry of Health.

Andrea Vecci女士還表示,目前的經營團隊的目標之一就是,藉由開發生產力之合作方式(PDP),創新IQUEGO的投資組合,與來自民營企業的產品技轉之提議,純粹是為附和衛生部的醫藥協助政策。

During the event, the governor Marconi Perillo (PSDB) recalled the importance of the strategic role of IQUEGO health of Goiás population since its creation during the government Mauro Borges in 1962, and recalled the production of low-cost medicines by Iquego when this production does not interest the major manufacturers of the private sector in the past, for example. "Iquego is one of the few companies in the country today responsible for producing four anti retroviral drug that makes up the framework of the anti cocktail AIDS in Brazil," he says.

在儀式期間,州長Marconi Perillo回憶說IQUEGO自從它創立起,也就是1962Mauro Borges政府期間,所扮演的策略角色在Goiania市民健康裡的重要性,還有由IQUEGO所生產的低價位藥物,以前這種方式並未引起民間大藥廠的意願,他舉例。”IQUEGO是一家國內少有的公司,在國內負責生產四種反逆轉錄病毒藥物用來調配抗禦愛滋病的藥

"This is an important step towards to the IQUEGO, maybe we can, in someday nearly, be here speaking of technological innovation created IQUEGO with fund financed by fostering research and the generation of new products. I wish that this is the first in a series of proactive meetings in order to transform this public laboratory in one of the country's largest, "he said.


The partnership will soon allow the transfer of advanced technology to the public sector of production of medicines in Goiás, already enables estimation of a target of achieving a market that reaches BRL 200 million per year, just within the next three years, according to Andrea Vecci.

這次合作將允許先進的技術,很快地移轉到GOIAS州內生產藥物的公家單位,據Andrea Vecci女士表示,在這短短的未來3年內,預估可達到每年2億元巴幣的市場價值的一個目標。

Through the partnership the government still estimateto generate 500 direct jobs in Goiás, as well as through the contract, the HMD Biomedical has a period of two years to set up a branch here in the state.

州政府預估,藉由這次合作,在GOIAS州內將造就500名直接員工的工作機會,同時也表示,HMD BioMedical也藉由這一份合約,在2年內將在州內設立一個子公司。

Fonte:EmaisGo (資料來源: EmaisGo)



Page 1 of 2